References
- IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 61. Schistosomes, liver flukes and Helicobacter pylori. IARC, Lyon 1994
- Forman D, Sitas F, Newell D G, et al. Geographic association of Helicobacter pylori antibody prevalence and gastric cancer mortality in rural China. Int J Cancer 1990; 46: 608–11
- The Eurogast Study Group. An international association between Helicobacter pylori infection and gastric cancer. Lancet 1993; 341: 1359–62
- Pukkala E, Rimpelä A, Läärä E. Cancer in Finland. Helsinki 1987, Cancer Society in Finland Publication No. 36
- Pukkala E, Gustavsson N, Teppo L. Atlas of Cancer Incidence in Finland. Helsinki 1987, Cancer Society of Finland Publication No. 37
- Howson C P, Hiyama T, Wynder E L. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1–27
- Muir C, Waterhouse J, Mack T, et al. Cancer Incidence in Five Continents. IARC, Lyon 1987; Vol V
- Sipponen P, Helske T, Järvinen P, et al. Decrease of prevalence of chronic gastritis in a period of 15 years; analysis of outpatient series in Finland from 1977, 1985 and 1992. Gut 1994; 35: 1167–71
- Sipponen P, Seppälä K. Long-term consequences of H. pylori infection: time trends in H. pylori gastritis, gastric cancer and peptic ulcer disease. Helicobacter pylori: Basic Mechanisms to Clinical Cure, R H Hunt, G NJ Tytgat. Kluwer Academic Publishers, Dordrecht 1994; 372–80
- Banatvala N, Nayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Dig Dis 1993; 168: 219–21
- Cullen D J, Collins B J, Cullen K J, et al. When is Helicobacter pylori infection acquired?. Gut 1993; 34: 1681–2
- Kuipers E J, Pena A S, van Kamp G, et al. Seroconversion for Helicobacter pylori. Lancet 1993; 342: 328–31